Daveen Chopra - 26 May 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Surgical Structural Heart
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 26 May 2022
Net transactions value: -$98,312
Form type: 4
Filing time: 26 May 2022, 20:06:15 UTC
Previous filing: 17 May 2022
Next filing: 02 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Sale	$98,312	-1,000	-4.8%	$98.31	19,911	26 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $98.295 to $98.370. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.